LARGE B-CELL LYMPHOMA
Clinical trials for LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo treatment aims to boost Cancer-Killing power of CAR-T therapy
Disease control Not yet recruitingThis early-stage study is testing whether giving a short course of targeted radiation therapy along with an oral antibiotic (vancomycin) is safe and feasible for patients with aggressive B-cell lymphomas before they receive standard CAR-T cell therapy. The goal is to see if this …
Matched conditions: LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New immune cell therapy targets Tough-to-Treat lymphomas
Disease control Not yet recruitingThis study is testing whether specially modified natural killer (NK) immune cells can help control two types of aggressive lymphoma that haven't responded well to standard treatments. Researchers will give these engineered cells to 100 adults whose lymphoma either didn't respond …
Matched conditions: LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New CAR T-Cell therapy aims to stop lymphoma in its tracks before it returns
Disease control Not yet recruitingThis study is testing whether a personalized immune cell therapy called liso-cel can prevent large B-cell lymphoma from returning. It's for patients who have finished their first round of treatment successfully but still have tiny traces of cancer DNA in their blood. Researchers …
Matched conditions: LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC